Your browser is no longer supported. Please, upgrade your browser.
AMRN Amarin Corporation plc weekly Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.41 Insider Own0.60% Shs Outstand267.81M Perf Week-3.29%
Market Cap865.03M Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float149.51M Perf Month-2.71%
Income-86.40M PEG- EPS next Q-0.07 Inst Own42.10% Short Float4.10% Perf Quarter8.03%
Sales130.10M P/S6.65 EPS this Y50.60% Inst Trans-0.96% Short Ratio3.73 Perf Half Y9.86%
Book/sh-0.12 P/B- EPS next Y75.00% ROA-52.20% Target Price5.33 Perf Year125.87%
Cash/sh0.37 P/C8.80 EPS next 5Y- ROE83.90% 52W Range1.40 - 3.65 Perf YTD4.87%
Dividend- P/FCF- EPS past 5Y5.10% ROI-91.10% 52W High-11.51% Beta0.80
Dividend %- Quick Ratio1.70 Sales past 5Y- Gross Margin73.60% 52W Low129.89% ATR0.13
Employees215 Current Ratio1.90 Sales Q/Q45.50% Oper. Margin-50.50% RSI (14)51.98 Volatility3.82% 4.18%
OptionableYes Debt/Eq- EPS Q/Q14.80% Profit Margin-66.40% Rel Volume0.59 Prev Close3.19
ShortableYes LT Debt/Eq- EarningsFeb 28 BMO Payout- Avg Volume1.64M Price3.23
Recom1.60 SMA20-0.48% SMA501.34% SMA2008.78% Volume977,055 Change1.25%
Oct-19-16Initiated Citigroup Buy $5
Oct-05-16Initiated Cantor Fitzgerald Buy $6
May-12-16Resumed Jefferies Buy
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Jul-20-10Initiated Wedbush Outperform $5
Mar-27-17 04:18PM  AMARIN CORP PLC\UK Files SEC form 8-K, Shareholder Director Nominations
Mar-21-17 08:09AM  4 Biotech Stocks With Jaw-Dropping Growth Potential at Motley Fool -5.09%
08:00AM  Amarin Corporation CEO, John Thero, to Chair the American Heart Associations Heart & Stroke Ball in New York City GlobeNewswire
Mar-16-17 05:00AM  Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study GlobeNewswire
Mar-15-17 09:56AM  Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology GlobeNewswire
Mar-08-17 01:04PM  AMARIN CORP PLC\UK Financials
Mar-07-17 12:22PM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
Mar-06-17 11:22AM  Here's What Pushed Amarin Corporation plc 15% Higher in February at Motley Fool
Mar-01-17 05:12PM  AMARIN CORP PLC\UK Files SEC form 10-K, Annual Report
Feb-28-17 09:22AM  Biotech Premarket Movers: Cempra, Novavax, Ionis
07:07AM  Q4 2016 Amarin Corporation PLC Earnings Release - Before Market Open
06:31AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
06:21AM  Amarin reports 4Q loss
06:00AM  Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations GlobeNewswire
Feb-23-17 10:07AM  Why President Trump Wants To Transform The FDA And What It Could Mean For Biotech Stocks at Insider Monkey
Feb-22-17 08:00AM  Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017 GlobeNewswire
Feb-09-17 07:50AM  Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-25-17 04:05PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl
Jan-20-17 07:19AM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
06:00AM  Amarin Announces Debt Restructuring and Related Private Placement of Exchangeable Senior Notes GlobeNewswire
Jan-18-17 06:46PM  FDA issues draft guidance to better medical product labeling Reuters
12:33PM  FDA proposes off-label communication norms for medical products Reuters
Jan-12-17 10:09AM  More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017 at Motley Fool
Jan-10-17 09:39AM  1 Reason Amarin's Stock Skyrocketed in 2016 at Motley Fool
Jan-05-17 04:47PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Amarin Provides Preliminary 2016 Results and 2017 Outlook GlobeNewswire
Dec-27-16 12:19PM  ETFs with exposure to Amarin Corp. Plc : December 27, 2016
Dec-21-16 09:30AM  Zacks.com featured highlights: Amarin, Two Harbors Investment, Fairmount Santrol Holdings, Vale and Oclaro
Dec-20-16 03:31PM  Explosive Stocks Under $10
Dec-16-16 04:31PM  Amarin Announces Contractual Reminder of Optional Put to Holders of $15.1 million Principal Amount of Outstanding 3.50% Exchangeable Senior Notes Due 2032 GlobeNewswire
04:09PM  AMARIN CORP PLC\UK Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Dec-13-16 02:05PM  Is CytomX Therapeutics Inc (CTMX) A Good Stock To Buy? at Insider Monkey
12:24PM  ETFs with exposure to Amarin Corp. Plc : December 13, 2016
Dec-11-16 08:46AM  Is Loxo Oncology Inc (LOXO) Worthy of Your Portfolio? at Insider Monkey
Dec-10-16 10:07AM  Is Modine Manufacturing Co. (MOD) A Good Stock To Buy? at Insider Monkey
Dec-08-16 07:14AM  Do Hedge Funds Love Amarin Corporation plc (ADR) (AMRN)? at Insider Monkey
Dec-05-16 11:24AM  Why Amarin (AMRN) Could Beat Earnings Estimates Again
Dec-02-16 08:37AM  Amarin (AMRN): Strong Industry, Solid Earnings Estimate Revisions
Nov-29-16 03:03PM  ETFs with exposure to Amarin Corp. Plc : November 29, 2016
Nov-24-16 05:48PM  The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 at Insider Monkey
Nov-20-16 07:26AM  Penny Stocks: 2 to Buy, 2 to Avoid at Motley Fool
Nov-18-16 09:55AM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 09:25AM  Patterson Companies (PDCO) Q2 Earnings: What's in Store?
09:14AM  Can Veeva Systems (VEEV) Pull a Surprise in Q3 Earnings?
Nov-14-16 07:30PM  Pure EPA Vascepa® (icosapent ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Parameters in Statin-Treated Women with Persistent High Triglycerides GlobeNewswire
Nov-11-16 10:27AM  Amarin to Present at the Jefferies 2016 London Healthcare Conference GlobeNewswire
Nov-09-16 08:52AM  Amarin's Stock Buckled in October. Is It Now a Bargain? at Motley Fool +6.51%
Nov-03-16 11:11AM  3 Important Things You Need to Know About Amarin's Q3 Results at Motley Fool -11.29%
07:07AM  Q3 2016 Amarin Corporation PLC Earnings Release - Before Market Open
06:11AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
05:36AM  Amarin reports 3Q loss
05:30AM  Amarin Reports Third Quarter 2016 Financial Results and Provides Update on Operations GlobeNewswire
Nov-02-16 04:05PM  Investor Calendar Invites You to the Amarin Third Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, November 3, 2016 Accesswire
Oct-27-16 04:56PM  Amarin to Report Third Quarter 2016 Results and Host Conference Call on November 3, 2016 GlobeNewswire
Oct-26-16 10:24AM  Amarin Corporation PLC (ADR) (AMRN) Renders Smaller Vascepa Capsule at Insider Monkey
Oct-25-16 07:00AM  Pure EPA Vascepa® Now Available in New, Smaller Half-Gram Capsule Size GlobeNewswire
Oct-23-16 09:05AM  10 Analyst Stocks Under $10 With Massive Upside Projections at 24/7 Wall St.
Oct-19-16 09:56AM  AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted
06:37AM  Coverage initiated on Amarin by Citigroup
Oct-18-16 09:23AM  Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia
Oct-17-16 10:00AM  Tetraphase Begins Phase III Dosing of Antibiotic Candidate
08:57AM  Allergan's Belkyra Gets Swedish Approval for Double Chin
Oct-14-16 10:03AM  Sunesis Submits Response to Questions on Leukemia Drug
09:59AM  OncoGenex Cancer Drug Fails in Phase III Study, Stock Down
Oct-13-16 02:30PM  Allergan Gets Priority Review for Avycaz Label Expansion
02:25PM  Supernus (SUPN) Reports Encouraging Data from ADHD Study
09:59AM  AMAG Issues Encouraging Updates on Makena & Feraheme
Oct-01-16 11:07AM  5 Small-Cap Stocks to Buy in October at Motley Fool
Sep-29-16 09:30AM  Will Amarin (AMRN) Continue to Surge Higher?
Sep-27-16 08:00AM  Amarin Corporation (AMRN) Looks Good: Stock Adds 6.1% in Session
Sep-24-16 09:09AM  Biotech Stocks Under $5: 2 to Buy, 1 to Avoid at Motley Fool
Sep-23-16 04:46PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events +8.89%
Sep-14-16 04:16PM  AMARIN CORP PLC\UK Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Statements and
Sep-12-16 06:31PM  Why Polaris Industries, Amarin, and VimpelCom Slumped Today at Motley Fool -6.94%
02:47PM  Raptor Pharmaceutical, Colgate-Palmolive Company & Others: Heres Why These Stocks Are Trending Today at Insider Monkey
05:00AM  Amarins REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee GlobeNewswire
Sep-07-16 04:36PM  Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys at Motley Fool
09:30AM  Zacks.com featured highlights: Amarin, Compugen, Raptor Pharmaceuticals, ArcelorMittal and Hovnanian Enterprises
07:30AM  Amarin to Present at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Sep-06-16 04:16PM  Explosive Stocks Under $10
Sep-02-16 07:40AM  8 Major FDA Decisions and Trial Results to Watch for in September at 24/7 Wall St.
Sep-01-16 10:20AM  Amarin (AMRN) Ends Patient Randomization in Vascepa Study
Aug-31-16 10:11AM  Is Amarin Corporation Stock a Solid Choice Right Now?
07:30AM  Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa GlobeNewswire
Aug-29-16 10:59AM  ETFs with exposure to Amarin Corp. Plc : August 29, 2016
Aug-26-16 04:37PM  AMARIN CORP PLC\UK Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits
04:20PM  Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in May 2014 and November 2015 GlobeNewswire
Aug-16-16 11:59AM  ETFs with exposure to Amarin Corp. Plc : August 16, 2016
Aug-15-16 01:20PM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
07:38AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Amarin Announces Underwriters Exercise of Option to Purchase Additional American Depositary Shares GlobeNewswire
Aug-12-16 04:12PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements
Aug-11-16 04:57PM  Why Shake Shack, Amarin, and Valeant Pharmaceuticals Slumped Today at Motley Fool -7.53%
02:50PM  A Look Into Latest Developments Surrounding Yahoo!, Kura Oncology, Kohls and Other Stocks at Insider Monkey
10:34AM  Amarin (AMRN) Stock Drops After Pricing Public Offering
09:20AM  Amarin Prices Public Offering of American Depositary Shares GlobeNewswire
08:08AM  Early movers: KSS, BABA, SHAK, GOOGL, VRX, AMZN, WMT & more at CNBC
Aug-10-16 04:10PM  Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire
Aug-04-16 09:56AM  Thursday Morning's Top Earnings Reports
08:27AM  Amarin reports 2Q loss
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.